Skip To Main Content
Leena Menghaney on Muck Rack

Leena Menghaney

As seen in: The Guardian, Hindustan Times, The BMJ, CNN-News18, The Hindu, News24, The Hindu Business Line, The Lancet, Scroll.in, Taipei Times and
Feminist working on access to treatment issues. Follow issues related to generic production and patents closely. Views are my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Leena

Contact Leena, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Addressing Discrimination and False Cures in Type 1 Diabetes: What we can learn from HIV Rights-based Response

|
By Leena Menghaney
| The Leaflet
INDIA HOSTED the first Global Summit to End Diabetes Stigma in Jaipur in March 2026. One of the main themes was the application of human rights law to address diabetes-related stigma in healthcare, education, and employment. The key question that emerged was this: what lessons can be drawn from the HIV rights-based response in combating discrimination and misinformation?
Open in Who Shared Issue with article?

WAAW 2025: Global South priorities are key for an equitable Global AMR Action Plan

|
By Leena Menghaney
| Down To Earth Verified
In the lead-up to shaping the draft Global Action Plan on Antimicrobial Resistance (AMR), the Delhi-based think tank Centre for Science and Environment (CSE) convened a consultation to gather the priorities and perspectives of diverse stakeholders across the Global South.
Open in Who Shared Issue with article?

Africa: A New HIV Prevention Jab Could End Aids - Unless Secrecy and Greed Get in the Way

|
By Fatima Hassan, Leena Menghaney, Bellinda Nkoana
| AllAfrica
A new HIV prevention jab has the potential to bring an end to the AIDS epidemic. But a lack of ambition and unjustifiable secrecy over pricing is holding it back, argue three leading health activists. Imagine a new HIV prevention tool existed that could - if it reached the right people - flick the switch to prevent almost all new HIV cases across the world.
Open in Who Shared View Duplicates (5) Issue with article?
See all 50 licensed articles (54 Total)